Get started
Author

Tatsuya Taniguchi

Observed names: Taniguchi, Tatsuya, Tatsuya TANIGUCHI
OpenAlex ID: A5113729330
MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma
2016 · Tetsu Tomonari, Shunsaku Takeishi, et al. · Oncotarget · 65
PDF
Serum diamine oxidase activity as a predictor of gastrointestinal toxicity and malnutrition due to anticancer drugs
2015 · Jinsei Miyoshi, Hiroshi Miyamoto, et al. · Journal of Gastroenterology and Hepatology · 59
Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib
2020 · Tetsu Tomonari, Yasushi Sato, et al. · Medicine · 47
MiR-125b-5p Is Involved in Sorafenib Resistance through Ataxin-1-Mediated Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
2021 · Akihiro Hirao, Yasushi Sato, et al. · Cancers · 32
PDF
Interindividual Diversity in Expression of Organic Anion Uptake Transporters in Normal and Cirrhotic Human Liver
2020 · Tatsuya Taniguchi, Alana Zanetti‐Yabur, et al. · Hepatology Communications · 29
PDF
Clinical Features and Outcomes of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma
2023 · Tetsu Tomonari, Joji Tani, et al. · Cancers · 28
PDF
Comparison of therapeutic outcomes of sorafenib and lenvatinib as primary treatments for hepatocellular carcinoma with a focus on molecular‐targeted agent sequential therapy: A propensity score‐matched analysis
2020 · Tetsu Tomonari, Yasushi Sato, et al. · Hepatology Research · 27
Potential use of lenvatinib for patients with unresectable hepatocellular carcinoma including after treatment with sorafenib: Real-world evidence and in vitro assessment via protein phosphorylation array
2020 · Tetsu Tomonari, Yasushi Sato, et al. · Oncotarget · 25
PDF
Initial therapeutic results of atezolizumab plus bevacizumab for unresectable advanced hepatocellular carcinoma and the importance of hepatic functional reserve
2022 · Tetsu Tomonari, Joji Tani, et al. · Cancer Medicine · 22
Novel des‐γ‐carboxy prothrombin in serum for the diagnosis of hepatocellular carcinoma
2013 · Takahiro Tanaka, Tatsuya Taniguchi, et al. · Journal of Gastroenterology and Hepatology · 22
Reducing Effect of Feeding Powdered Nacre ofPinctada maximaon the Visceral Fat of Rats
2008 · Masayuki SHONO, Ichiro SHIMIZU, et al. · Bioscience Biotechnology and Biochemistry · 21
Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome
2020 · Masahiro Sogabe, Toshiya Okahisa, et al. · PLoS ONE · 20
PDF
Light alcohol consumption plays a protective role against non‐alcoholic fatty liver disease in Japanese men with metabolic syndrome
2014 · Masahiro Sogabe, Toshiya Okahisa, et al. · Liver International · 19
Sorafenib as second‐line treatment option after failure of lenvatinib in patients with unresectable hepatocellular carcinoma
2020 · Tetsu Tomonari, Yasushi Sato, et al. · JGH Open · 18
PDF
Chemoprevention of colorectal cancer-experimental and clinical aspects-
2009 · Tetsuji Takayama, Takahiro Goji, et al. · The Journal of Medical Investigation · 17
PDF
Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma
2021 · Tetsu Tomonari, Yasushi Sato, et al. · JGH Open · 15
APOB codon 4311 polymorphism is associated with hepatitis C virus infection through altered lipid metabolism
2018 · Rie Harada, Masako Kimura, et al. · BMC Gastroenterology · 15
PDF
Characteristics and Prognosis of Hepatocellular Carcinoma in Japanese Patients Undergoing Dialysis
2017 · Hidenori Toyoda, Atsushi Hiraoka, et al. · Therapeutic Apheresis and Dialysis · 15
Multicenter retrospective study of initial treatment outcome and feasibility of initiating dose reduction of cabozantinib in unresectable hepatocellular carcinoma
2022 · Tetsu Tomonari, Joji Tani, et al. · Hepatology Research · 13
Sequential therapy including regorafenib for unresectable hepatocellular carcinoma: Effect of early relative changes in hepatic functional reserve after regorafenib administration on prognosis
2021 · Hironori Ochi, Joji Tani, et al. · Hepatology Research · 12
Influence of light alcohol consumption on lifestyle-related diseases: a predictor of fatty liver with liver enzyme elevation in Japanese females with metabolic syndrome
2016 · Masahiro Sogabe, Toshiya Okahisa, et al. · BMC Gastroenterology · 12
PDF
Influence of alcohol on newly developed metabolic dysfunction-associated fatty liver disease in both sexes: A longitudinal study
2023 · Masahiro Sogabe, Toshiya Okahisa, et al. · Clinical Nutrition · 10
PDF
An Adult Case of Congenital Extrahepatic Portosystemic Shunt Successfully Treated with Balloon-occluded Retrograde Transvenous Obliteration
2021 · Hironori Tanaka, Yoshihito Saijo, et al. · Internal Medicine · 10
PDF
Clinical features of hemodialysis patients treated for hepatocellular carcinoma: Comparison between resection and radiofrequency ablation
2017 · Atsushi Hiraoka, Takashi Kumada, et al. · Molecular and Clinical Oncology · 10
PDF
Comparison of the role of alcohol consumption and qualitative abdominal fat on NAFLD and MAFLD in males and females
2022 · Masahiro Sogabe, Toshiya Okahisa, et al. · Scientific Reports · 9
PDF
Works count: 52
Citation count: 598
H-index: 15
I10-index: 24
Year
Topic
Type